Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
Atrium Health-Formerly known as Carolinas HealthCare System

2. Address

Address1
P.O. BOX 32861
 Address2
​
City
CHARLOTTE
 State
NC
 Zip Code
28232-2861
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mrs.
​Martha Ann McConnell
​7046141538
​marthaann.mcconnell@atriumhealth.org
5. Senate ID#
​58534-12
7. Client Name Self Check if client is a state or local government or instrumentality
​Atrium Health - Formerly known as Carolinas HealthCare System
6. House ID#
​352080000
TYPE OF REPORT 8. Year
​2022
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​239,465.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Martha Ann McConnell
 Date
4/20/2022 3:41:24 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

Any bill(s), provision(s), or action(s) impacting the 340B Drug Discount Program and hospitals and health systems ability to provide access to these drugs for patients. S.773 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.

Any bill(s) or provision(s) addressing high drug prices.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Martha Ann
McConnell
​
​
Kristen
Morris
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues


Any COVID-19 stimulus bill(s), package(s), or provision(s) impacting hospitals and health systems, including but not limited to:
Forgiveness for Medicare accelerated payments;
Additional money and reporting requirements for the Provider Relief Fund;
Support for front-line caregivers;
Liability protections for front-line medical providers and facilities;
Maintaining health benefits for individuals and families and increasing coverage options for the uninsured;
Expansion of resources for testing, tracing, and vaccine development; and
Expansion of resources for vaccine rollout and administration.
Extension of Certain Public Health Emergency coverage policies.

Any requirement(s) for hospitals to collect and report COVID-19 data.

Any bill(s) or provision(s) urging the delay of CMSs hospital transparency rule requiring hospitals to publicly disclose negotiated rates with commercial health plans.

Any provision(s) on the CMS hospital outpatient prospective payment system/ ambulatory surgical center proposed rule reducing payment rates received by hospitals.

Any bill(s), provision(s), or action(s) impacting the 340B Drug Discount Program and hospitals and health systems ability to provide access to these drugs for patients. S.773 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.

Any bill(s) or provision(s) addressing high drug prices.

Any bill(s) or provision(s) addressing surprise medical billing proposals harmful to patients and hospitals/health systems. The No Surprises Act.

Any bill(s) or provision(s) enabling or making it easier for providers to use telemedicine to increase access for patients. Any provision(s) expanding telehealth services and access.

Any issue(s) related to Medicare pass-through funding and other payment technicalities in relation to colleges of nursing and allied health professions.

Any bill(s) or provision(s) addressing Medicaid Disproportionate Share Hospital (DSH) cuts, namely having to do with a delay in cuts.

Any bill(s) or provision(s) addressing access to mental health care for patients.

Any bill(s) or provision(s) addressing access to rural health care for patients.

Bill(s) or provision(s) addressing the elimination of Medicare sequester cuts during the COVID-19 public health emergency.

Any bill(s) or provision(s) addressing the expansion of Medicaid and increasing the level of Federal matching assistance for states that choose to expand Medicaid coverage.

Any bill(s) or provision(s) relating to funding for the Atrium Health/Wake Forest Baptist Innovation Quarter, Innovation Corridor, and The Pearl.

Any bill(s) or provision(s) relating to funding/support for the Atrium Health/Wake Forest Baptist School of Medicine research.

Any bill(s) or provision(s) related to workforce and continued support for healthcare workers. S.1024 - HEALTHCARE WORKFORCE RESILIENCE ACT; S 834: RESIDENT PHYSICIAN SHORTAGE REDUCTION ACT OF 2021; S. 1024: HEALTHCARE WORKFORCE RESILIENCE ACT.

Any bill(s) or provision(s) related to pandemic preparedness including S.3799 the PREVENT Pandemics Act

Any bill(s) or provision(s) related to telehealth coverage and extending the hospital@home demonstration program. Any bill(s) or provision(s) related to increased resources to care for rural and urban underserved communities.

Any bill(s) or provision(s) related to health care research and innovation including ARPA-H.

Any bill(s) or provision(s) related to workforce violence and protection of healthcare workers.

Any bill(s) or provision(s) concerning the DoD Appropriations for the Wake Forest Institute for Regenerative Medicine (WFIRM).

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Martha Ann
McConnell
​
​
Kristen
Morris
​
​
Jimmy
Broughton
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Any COVID-19 stimulus bill(s), package(s), or provision(s) impacting hospitals and health systems, including but not limited to:
Forgiveness for Medicare accelerated payments;
Additional money and reporting requirements for the Provider Relief Fund;
Support for front-line caregivers;
Liability protections for front-line medical providers and facilities;
Maintaining health benefits for individuals and families and increasing coverage options for the uninsured;
Expansion of resources for testing, tracing, and vaccine development; and
Expansion of resources for vaccine rollout and administration.
Extension of Certain Public Health Emergency coverage policies.

Any bill(s) or provision(s) relating to funding for the Atrium Health/Wake Forest Baptist Innovation Quarter, Innovation Corridor, and The Pearl.

Any bill(s) or provision(s) relating to funding/support for the Atrium Health/Wake Forest Baptist School of Medicine research.

Any bill(s) or provision(s) concerning the DoD Appropriations for the Wake Forest Institute for Regenerative Medicine (WFIRM).

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Martha Ann
McConnell
​
​
Kristen
Morris
​
​
Jimmy
Broughton
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LBR

16. Specific lobbying issues

Any bill(s) or provision(s) related to workforce and continued support for healthcare workers. S.1024 - HEALTHCARE WORKFORCE RESILIENCE ACT; S 834: RESIDENT PHYSICIAN SHORTAGE REDUCTION ACT OF 2021; S. 1024: HEALTHCARE WORKFORCE RESILIENCE ACT.

Any COVID-19 stimulus bill(s), package(s), or provision(s) impacting hospitals and health systems, including but not limited to:
Forgiveness for Medicare accelerated payments;
Additional money and reporting requirements for the Provider Relief Fund;
Support for front-line caregivers;
Liability protections for front-line medical providers and facilities;
Maintaining health benefits for individuals and families and increasing coverage options for the uninsured;
Expansion of resources for testing, tracing, and vaccine development; and
Expansion of resources for vaccine rollout and administration.

Any issue(s) related to Medicare pass-through funding and other payment technicalities in relation to colleges of nursing and allied health professions.

Any bill(s) or provision(s) related to workforce violence and protection of healthcare workers.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Martha Ann
McConnell
​
​
Kristen
Morris
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Any bill(s) or provision(s) urging the delay of CMSs hospital transparency rule requiring hospitals to publicly disclose negotiated rates with commercial health plans.

Any provision(s) on the CMS hospital outpatient prospective payment system/ ambulatory surgical center proposed rule reducing payment rates received by hospitals.

Any issue(s) related to Medicare pass-through funding and other payment technicalities in relation to colleges of nursing and allied health professions.

Any bill(s) or provision(s) addressing Medicaid Disproportionate Share Hospital (DSH) cuts, namely having to do with a delay in cuts.

Bill(s) or provision(s) addressing the elimination of Medicare sequester cuts during the COVID-19 public health emergency.

Any bill(s) or provision(s) addressing the expansion of Medicaid and increasing the level of Federal matching assistance for states that choose to expand Medicaid coverage.


17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Martha Ann
McConnell
​
​
Kristen
Morris
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TEC

16. Specific lobbying issues

Any bill(s) or provision(s) enabling or making it easier for providers to use telemedicine to increase access for patients. Any provision(s) expanding telehealth services and access.

Any bill(s) or provision(s) related to telehealth coverage and extending the hospital@home demonstration program. Any bill(s) or provision(s) related to increased resources to care for rural and urban underserved communities.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Martha Ann
McConnell
​
​
Kristen
Morris
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)